Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenetic Biosciences (XBIO) Current Assets (2023 - 2025)

Xenetic Biosciences (XBIO) has disclosed Current Assets for 5 consecutive years, with $5.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Current Assets fell 27.89% year-over-year to $5.1 million, compared with a TTM value of $5.1 million through Sep 2025, down 27.89%, and an annual FY2024 reading of $6.6 million, down 31.29% over the prior year.
  • Current Assets was $5.1 million for Q3 2025 at Xenetic Biosciences, down from $5.4 million in the prior quarter.
  • Across five years, Current Assets topped out at $12.9 million in Q1 2023 and bottomed at $5.1 million in Q3 2025.
  • Average Current Assets over 3 years is $8.3 million, with a median of $8.0 million recorded in 2024.
  • The sharpest move saw Current Assets crashed 37.57% in 2024, then dropped 27.89% in 2025.
  • Year by year, Current Assets stood at $9.6 million in 2023, then crashed by 31.29% to $6.6 million in 2024, then decreased by 23.07% to $5.1 million in 2025.
  • Business Quant data shows Current Assets for XBIO at $5.1 million in Q3 2025, $5.4 million in Q2 2025, and $5.5 million in Q1 2025.